Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001230724-26-000012

PRESIDENT AND CFO sold 10,000 shares at an average $57.28 ($572,837)

  • PRESIDENT AND CFO acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GUGGENHIME ANDREW · PRESIDENT AND CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-06 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $5.35 $53,500 114,395 D
2026-07-06 Sale : show line 2 in the form 10b5-1 −7,913 $57.16 $452,283 106,482 D
2026-07-06 Sale : show line 3 in the form 10b5-1 −2,087 $57.76 $120,553 104,395 D
Open-market sales · 10,000 sh · avg $57.28 · $572,837

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-06 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −10,000 226,827 D
Loading xslF345X06/wk-form4_1783380710.xml…